Insider Transactions in Q1 2023 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 10
2023
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
193,074
+25.16%
|
$386,148
$2.21 P/Share
|
Mar 01
2023
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
3,500
-19.65%
|
$280,000
$80.1 P/Share
|
Mar 01
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-21.02%
|
$395,000
$79.51 P/Share
|
Mar 01
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.37%
|
$80,000
$16.14 P/Share
|
Mar 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-0.97%
|
$600,000
$80.59 P/Share
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Indirect |
5,000
-20.18%
|
$400,000
$80.06 P/Share
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-41.03%
|
$800,000
$80.15 P/Share
|
Feb 28
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+29.09%
|
$160,000
$16.14 P/Share
|
Feb 28
2023
|
Edwin M Kania Jr |
BUY
Other acquisition or disposition
|
Direct |
242,477
+37.53%
|
$19,155,683
$79.76 P/Share
|
Feb 27
2023
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
5,000
-7.9%
|
$385,000
$77.92 P/Share
|
Feb 27
2023
|
David Weill |
SELL
Open market or private sale
|
Direct |
5,934
-19.62%
|
$456,918
$77.08 P/Share
|
Feb 27
2023
|
David Weill |
BUY
Exercise of conversion of derivative security
|
Direct |
5,934
+27.14%
|
$83,076
$14.2 P/Share
|
Feb 23
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
35,930
-15.68%
|
$2,586,960
$72.84 P/Share
|
Feb 23
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,930
+23.91%
|
$574,880
$16.07 P/Share
|
Feb 23
2023
|
James R Tobin |
SELL
Open market or private sale
|
Indirect |
10,000
-3.94%
|
$750,000
$75.13 P/Share
|
Feb 23
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
37,827
-1.83%
|
$2,723,544
$72.95 P/Share
|
Feb 20
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,075
+41.03%
|
-
|
Feb 20
2023
|
Waleed H Hassanein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,332
+8.05%
|
-
|
Feb 20
2023
|
Nicholas Corcoran |
BUY
Grant, award, or other acquisition
|
Direct |
12,886
+50.0%
|
-
|
Feb 20
2023
|
Laura Damme VP, Clinical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+50.0%
|
-
|
Feb 20
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,075
+47.63%
|
-
|
Feb 20
2023
|
Miriam Provost VP, Global Regulatory Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
5,685
+21.43%
|
-
|
Feb 14
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,070
-75.79%
|
$284,900
$70.15 P/Share
|
Feb 14
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,070
+43.11%
|
$65,120
$16.0 P/Share
|
Feb 14
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
2,173
-0.56%
|
$152,110
$70.08 P/Share
|
Feb 01
2023
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
1,410
-1.88%
|
$88,830
$63.85 P/Share
|
Feb 01
2023
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,410
+4.2%
|
$38,070
$27.3 P/Share
|
Feb 01
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-46.67%
|
$310,000
$62.64 P/Share
|
Feb 01
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.82%
|
$80,000
$16.14 P/Share
|
Feb 01
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-1.88%
|
$480,000
$64.21 P/Share
|
Jan 23
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
12,362
-1.51%
|
$803,530
$65.74 P/Share
|
Jan 23
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,142
-70.73%
|
$204,230
$65.07 P/Share
|
Jan 23
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,142
+41.43%
|
$50,272
$16.0 P/Share
|
Jan 20
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,558
-81.04%
|
$361,270
$65.21 P/Share
|
Jan 20
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,558
+44.76%
|
$88,928
$16.0 P/Share
|
Jan 20
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
6,332
-1.52%
|
$411,580
$65.19 P/Share
|
Jan 18
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,300
-50.0%
|
$84,500
$65.11 P/Share
|
Jan 18
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+33.33%
|
$20,800
$16.0 P/Share
|
Jan 18
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
1,306
-0.31%
|
$84,890
$65.09 P/Share
|
Jan 17
2023
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
7,500
-1.76%
|
$480,000
$64.14 P/Share
|
Jan 17
2023
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-46.67%
|
$300,000
$60.12 P/Share
|
Jan 17
2023
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.82%
|
$80,000
$16.14 P/Share
|
Jan 17
2023
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
1,410
-1.88%
|
$87,420
$62.59 P/Share
|
Jan 17
2023
|
John F Carey VP of Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,410
+8.32%
|
$53,580
$38.46 P/Share
|
Jan 13
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,900
-81.94%
|
$354,000
$60.2 P/Share
|
Jan 13
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,900
+45.04%
|
$94,400
$16.0 P/Share
|
Jan 03
2023
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,100
-34.81%
|
$250,100
$61.9 P/Share
|
Jan 03
2023
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,100
+43.16%
|
$65,600
$16.0 P/Share
|